Literature DB >> 19672066

Concentrations of metals, beta-amyloid and tau-markers in cerebrospinal fluid in patients with Alzheimer's disease.

Lars Gerhardsson1, Kaj Blennow, Thomas Lundh, Elisabet Londos, Lennart Minthon.   

Abstract

BACKGROUND/AIMS: In this study, metal concentrations were related to the levels of well-known Alzheimer markers in cerebrospinal fluid (CSF), such as amyloid-beta (Abeta), total tau (T-tau) and phosphorylated-tau (P-tau).
METHODS: Concentrations of 19 metals (Mg, Ca, V, Mn, Fe, Co, Ni, Cu, Zn, Se, Rb, Sr, Mo, Cd, Sn, Sb, Cs, Hg and Pb by inductively coupled plasma-mass spectrometry) and the levels of Abeta, T-tau and P-tau in CSF were determined (xMAP technology) in 264 patients with Alzheimer's disease (AD), and in 54 healthy referents.
RESULTS: The AD subjects showed positive correlations between CSF-T-tau and CSF-P-tau versus CSF-Mn (r(s) = 0.22, p = 0.004; r(s) = 0.18, p = 0.021). CSF-T-tau, however, showed a negative correlation with CSF-Cs (r(s) = -0.17; p = 0.027). In subjects with severe AD, CSF-Abeta showed a strong positive correlation with CSF-Cs (r(s) = 0.49; p = 0.026), while CSF-T-tau showed a strong negative correlation with CSF-Cs (r(s) = -0.49; p = 0.026). Also, CSF P-tau was negatively associated with CSF-Cs (r(s) = -0.41; p = 0.06).
CONCLUSION: The different relationships between the CSF-levels of Abeta and tau-markers versus the levels of CSF-Mn and CSF-Cs may be due to different binding affinity between these metals and metal binding proteins in the CSF and the surrounding brain. Copyright 2009 S. Karger AG, Basel.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19672066     DOI: 10.1159/000233353

Source DB:  PubMed          Journal:  Dement Geriatr Cogn Disord        ISSN: 1420-8008            Impact factor:   2.959


  9 in total

1.  Comparison of Metal Levels between Postmortem Brain and Ventricular Fluid in Alzheimer's Disease and Nondemented Elderly Controls.

Authors:  Steven T Szabo; G Jean Harry; Kathleen M Hayden; David T Szabo; Linda Birnbaum
Journal:  Toxicol Sci       Date:  2015-12-31       Impact factor: 4.849

2.  Cerebrospinal fluid/plasma quotients of essential and non-essential metals in patients with Alzheimer's disease.

Authors:  Lars Gerhardsson; Thomas Lundh; Elisabet Londos; Lennart Minthon
Journal:  J Neural Transm (Vienna)       Date:  2011-03-04       Impact factor: 3.575

Review 3.  The Role of Selenium in Pathologies: An Updated Review.

Authors:  Giulia Barchielli; Antonella Capperucci; Damiano Tanini
Journal:  Antioxidants (Basel)       Date:  2022-01-27

4.  Cadmium and Alzheimer's disease mortality in U.S. adults: Updated evidence with a urinary biomarker and extended follow-up time.

Authors:  Qing Peng; Kelly M Bakulski; Bin Nan; Sung Kyun Park
Journal:  Environ Res       Date:  2017-05-13       Impact factor: 6.498

5.  Overdosing on iron: Elevated iron and degenerative brain disorders.

Authors:  Santosh R D'Mello; Mark C Kindy
Journal:  Exp Biol Med (Maywood)       Date:  2020-09-02

6.  A selenium species in cerebrospinal fluid predicts conversion to Alzheimer's dementia in persons with mild cognitive impairment.

Authors:  Marco Vinceti; Annalisa Chiari; Marcel Eichmüller; Kenneth J Rothman; Tommaso Filippini; Carlotta Malagoli; Jennifer Weuve; Manuela Tondelli; Giovanna Zamboni; Paolo F Nichelli; Bernhard Michalke
Journal:  Alzheimers Res Ther       Date:  2017-12-19       Impact factor: 6.982

7.  The association of heavy metal of blood and serum in the Alzheimer's diseases.

Authors:  Ji-Yeon Lee; Jae-Hoon Kim; Dal-Woong Choi; Dong-Woo Lee; Jun-Hyun Park; Hye-Jung Yoon; Hee-Soo Pyo; Ho-Jang Kwon; Kyung-Su Park
Journal:  Toxicol Res       Date:  2012-06

8.  Association between dental amalgam fillings and Alzheimer's disease.

Authors:  Amin Zarghami; Seyyed Mohammad Masoud Hojjati
Journal:  Alzheimers Res Ther       Date:  2016-01-18       Impact factor: 6.982

Review 9.  Disease Ionomics: Understanding the Role of Ions in Complex Disease.

Authors:  Yan Zhang; Yinzhen Xu; Lin Zheng
Journal:  Int J Mol Sci       Date:  2020-11-17       Impact factor: 5.923

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.